356 results on '"Rohde, Luis E."'
Search Results
2. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction patients: A meta-analysis
3. Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials
4. Are the recommendation of sodium and fluid restriction in heart failure patients changing over the past years? A systematic review and meta-analysis
5. Growth/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy
6. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis
7. REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed
8. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial
9. Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial.
10. Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure
11. Predictors of serious arrhythmic events in patients with nonischemic heart failure
12. Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
13. QRS Widening Rates and Genetic Polymorphisms of Matrix Metalloproteinases in a Cohort of Patients With Chronic Heart Failure
14. Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: The perspective of a middle-income country's public health system
15. The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure
16. NYHA classification for decision‐making in heart failure: Time to reassess?
17. Polymorphisms of endothelial nitric oxide synthase gene in systolic heart failure: An haplotype analysis
18. Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF
19. Reduction of dietary sodium for heart failure: a step forward
20. Polymorphisms of Matrix Metalloproteinases in Systolic Heart Failure: Role on Disease Susceptibility, Phenotypic Characteristics, and Prognosis
21. Asymptomatic left ventricular dysfunction in puerperal women: An echocardiographic-based study
22. Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients
23. Effect of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies
24. Is There Room for Sacubitril-Valsartan in the Treatment of Advanced Heart Failure?
25. Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission
26. Bradykinin or Acetylcholine as Vasodilators to Test Endothelial Venous Function in Healthy Subjects
27. Effects of 5′-Phosphodiesterase Four-Week Long Inhibition With Sildenafil in Patients With Chronic Heart Failure: A Double-Blind, Placebo-Controlled Clinical Trial
28. Impact of β1-Adrenergic Receptor Polymorphisms on Susceptibility to Heart Failure, Arrhythmogenesis, Prognosis, and Response to Beta-Blocker Therapy
29. A New Algorithm for Weekly Phenprocoumon Dose Variation in a Southern Brazilian Population: Role for CYP2C9, CYP3A4/5 and VKORC1 Genes Polymorphisms
30. Effects of a diuretic adjustment algorithm protocol on heart failure admissions: A randomized clinical trial
31. Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction: Diagnosis of adriamycin cardiotoxicity
32. Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan:Insights from a Combined PARAGON-HF and PARADIGM-HF Analysis
33. A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure
34. Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM‐HF analysis
35. Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan
36. Reply
37. Cost-effectiveness of heart failure therapies
38. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure
39. A Simple Clinically Based Predictive Rule for Heart Failure In-Hospital Mortality
40. Impact of redefining acute myocardial infarction on incidence, management and reimbursement rate of acute coronary syndromes
41. Algorithms for Cardiac Amyloidosis Diagnosis: How to apply them in practice?
42. Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II
43. COVID-19 in Brazil: the headlines should be about science
44. Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure
45. Nurses’ performance in classifying heart failure patients based on physical exam: comparison with cardiologistʼs physical exam and levels of N-terminal pro-B-type natriuretic peptide
46. Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure
47. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability
48. Superoxide Dismutase Activity in Adriamycin-Induced Cardiotoxicity in Humans: A Potential Novel Tool for Risk Stratification
49. Left atrial appendage assessment by second harmonic transthoracic echocardiography after an acute ischemic neurologic event
50. Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.